• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec12
Akorda Pharma Receives FDA Approval for DAYBUE STIX
13:28
Nov6
Acadia Pharma released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 278.63 M (forecast USD 276.54 M), actual EPS USD 0.42 (forecast USD 0.1435)
00:00
Acadia Pharma released FY2025 9 Months earnings on November 5 After-Market (EST), actual revenue USD 787.52 M, actual EPS USD 0.6888
00:00
Oct29
Acadia Pharma to release FY2025 Q3 earnings on November 5 After-Market EST, forecast revenue USD 276.54 M, EPS USD 0.1435
00:29
Sep25
TR | OpenAI – 4o downgrades ACADIA Pharmaceuticals to hold
10:56
Aug6
Acadia Pharma released FY2025 Q2 earnings on August 6 After-Market EST, actual revenue USD 264.57 M (forecast USD 262 M), actual EPS USD 0.1588 (forecast USD 0.1335)
23:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 278.63 M, Net Income 71.78 M, EPS 0.42

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 264.57 M, Net Income 26.67 M, EPS 0.1588

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 244.32 M, Net Income 18.99 M, EPS 0.11

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More